Olena Bracho

Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2–associated schwannomas reveals differences in efficacy and drug resistance development

Marisa A. Fuse, Christine T. Dinh, Jérémie Vitte et al. · Neuro-Oncology · 2019 · 39 citations · Full text

Medicine, Cancer Biology, Oncology +17

Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells

Alejandra M. Petrilli, Jeanine Garcia, Marga Bott et al. · Oncotarget · 2017 · 35 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells

Marisa A. Fuse, Stephani Klingeman Plati, Sarah S. Burns et al. · Molecular Cancer Therapeutics · 2017 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Laminin-coated electrodes improve cochlear implant function and post-insertion neuronal survival

Esperanza Bas, Mir R. Anwar, Stefania Goncalves et al. · Neuroscience · 2019 · 22 citations

Health Professions, Neuroscience, Otolaryngology +16

Modulation of BDNF–TRKB Interactions on Schwann Cell-induced Oral Squamous Cell Carcinoma Dispersion <i>In Vitro</i>

Liliana Ein, Christine Mei, Olena Bracho et al. · Anticancer Research · 2019 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +17